ABBV Stock Latest News

AbbVie upgraded to Outperform from Market Perform at Leerink

PremiumThe Fly

4d ago

PremiumMarket News3 Best Stocks to Buy Now, 11/19/2024, According to Top Analysts

7d ago

ATEC

The Fly

AbbVie receives EC approval of Elahere

8d ago

The Fly

Wolfe starts AbbVie at Outperform, says valuation an attractive entry point

11d ago

AbbVie initiated with an Outperform at Wolfe Research

PremiumThe Fly

11d ago

JPMorgan trims AbbVie target, removes from Analyst Focus List

PremiumThe Fly

13d ago

Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz

PremiumThe Fly

14d ago

PremiumThe Fly

Bristol Myers price target raised to $61 from $57 at BMO Capital

14d ago

PremiumThe FlyNvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls

14d ago

AbbVie price target lowered to $208 from $228 at BMO Capital

The Fly

AbbVie price target lowered to $208 from $228 at BMO Capital

14d ago

Bristol Myers price target raised to $39 from $36 at Morgan Stanley

The Fly

Bristol Myers price target raised to $39 from $36 at Morgan Stanley

14d ago

AbbVie price target lowered to $224 from $231 at Morgan Stanley

PremiumThe Fly

14d ago

Leerink upgrades Bristol to Outperform after AbbVie schizophrenia failure

PremiumThe Fly

14d ago

AbbVie price target lowered to $215 from $226 at Citi

PremiumThe Fly

14d ago

Cigna drops pursuit of Humana: Morning Buzz

PremiumThe Fly

15d ago

PremiumThe FlyEvercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive

15d ago

The Fly

AbbVie under pressure as schizophrenia drug fails two trials

15d ago

The Fly

Leerink sees AbbVie’s trial results as ‘clear positive’ for Bristol Myers

15d ago